Develops NK-cell antibody immunotherapies for cancer
| Date | Round | Amount |
|---|---|---|
| Dec 2021 | Series A Biotech Zumutor Biologics raised $6.2M in a Series A4 led by Siana Capital, with Accel and Bharat Innovation Fund, to advance its prostate-cancer antibody. | $6.2M |